Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biotechnology

HTL doubles its hyaluronic acid capacity

by Craig Bettenhausen
October 15, 2021 | A version of this story appeared in Volume 99, Issue 38

 

A photo of a person in PPE and clean-room garb looking into a large steel fermentation vessel.
Credit: HTL Biotechnology
A worker inspects a fermenter at HTL's hyaluronic acid plant.

HTL Biotechnology has more than doubled its capacity to make hyaluronic acid via fermentation at its facility in Javené, France. HTL says the $58 million investment will make it the world’s largest producer of pharmaceutical-grade hyaluronic acid. Orthopedists use hyaluronic acid injections to treat joint pain, and cosmetic surgeons use them to fill in sunken areas of the face, among other applications. Though HTL uses fermentation, some producers extract hyaluronic acid from chicken combs.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.